PEG-MGF
Pegylated IGF-1 splice variant (Mechano Growth Factor)
A pegylated form of Mechano Growth Factor, a splice variant of IGF-1 linked to muscle repair. Human data are limited and its use is investigational.
Mechanism under study
MGF (an IGF-1 splice variant expressed after mechanical loading or damage) is proposed to activate muscle satellite (stem) cells to support local repair and growth; PEGylation is intended to slow clearance and prolong exposure.
Research-reported dosing
No established human dosing; use is investigational/preclinical. Research-community sources reference roughly 200-400 mcg per dose.
5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.
A 300 mcg dose ≈ 12 units (25 mcg per unit).
Open this mix in the calculator →Dosing figures describe how this compound appears in the research literature and research-community references. They are not a recommendation for human use.
PEG-MGF FAQ
What is PEG-MGF?
A pegylated form of Mechano Growth Factor, a splice variant of IGF-1 linked to muscle repair. Human data are limited and its use is investigational.
What is the half-life of PEG-MGF?
Native MGF is cleared within minutes; PEGylation is intended to extend this to hours or longer, though human data are lacking.
What is the research-reported dosing for PEG-MGF?
No established human dosing; use is investigational/preclinical. Research-community sources reference roughly 200-400 mcg per dose.
How is PEG-MGF reconstituted?
5 mg vial + 2 mL bacteriostatic water = 2500 mcg/mL.
Is PEG-MGF FDA-approved?
No — PEG-MGF is investigational and not FDA-approved. It is sold for laboratory research use only.
References
Related peptides
IGF-1 LR3
Recombinant IGF-1 analog
A modified, long-acting analog of insulin-like growth factor 1 widely used as a research reagent in cell-culture and preclinical growth studies.
CJC-1295
Growth-hormone-releasing hormone (GHRH) analog
A synthetic GHRH analog studied for stimulating growth-hormone release. Exists in a short-acting 'no-DAC' form (modified GRF 1-29) and a long-acting 'DAC' form.
Ipamorelin
Ghrelin-receptor agonist (GH secretagogue)
A selective ghrelin-receptor agonist studied for stimulating growth-hormone release with comparatively little effect on cortisol or prolactin, making it a frequently referenced 'clean' secretagogue.
Follistatin-344
Recombinant follistatin isoform (glycoprotein)
A recombinant isoform of follistatin, a natural inhibitor of myostatin, studied for its potential to increase muscle mass. Most human work uses gene therapy rather than the injected protein.